CVC Capital Partners is evaluating a potential sale of Arthea, the privately held personal care platform whose portfolio includes Dr. Teal’s, in a process that could value the company at roughly $2 billion, according to people familiar with the matter. The sources, who requested anonymity because the deliberations are private, said CVC is working with investment banks Moelis and William Blair on the possible transaction.
Those close to the talks emphasized that discussions remain at an early stage. CVC and Moelis declined to comment when contacted. Arthea and William Blair did not respond to requests for comment.
If a sale of Arthea were to materialize, it would come amid an active year for dealmaking in the personal care and beauty sector. Several sizable transactions and processes have been underway this year: a proposed combination between Estee Lauder and Puig did not reach completion; L'Oreal closed its $4.7 billion acquisition of Kering’s beauty unit in March; Henkel purchased Olaplex for $1.4 billion; and Advent reached an agreement to acquire body care brand Salt & Stone for an undisclosed sum. In addition, Wella Company, which is backed by KKR and owns the OPI nail polish brand, filed for a U.S. initial public offering last week, underscoring public-market interest in consumer names.
Last month PDC Brands, from which Arthea evolved, announced a corporate rebrand and started using the name Arthea. The company said the new name was inspired by the words art and healing. Around the same time it introduced a new body care offering called Sunryz, positioned toward tweens.
CVC originally acquired PDC from Yellow Wood Partners in 2017 for $1.43 billion. Arthea traces its corporate roots back to 1981 and is headquartered in White Plains, New York. The platform’s brand roster includes bath and body labels Dr. Teal’s and Bodycology, fragrance lines Body Fantasies and BOD Man, and textured hair care brand Cantu. According to its website, Arthea’s products are sold in more than 80 countries.
CVC’s private equity business is based in Luxembourg and the firm manages assets totaling €115 billion, listed in the article as equivalent to $131.4 billion using an exchange rate of $1 = 0.8753 euros. The sources did not provide further details on timing, potential buyers, or the structure of any contemplated transaction.
Market context
The potential Arthea process reflects continuing consolidation and investor interest in consumer personal care brands, where strategic buyers and sponsors have pursued scale through acquisitions and platform investments. While the current talks are preliminary, a completed deal at the reported valuation would rank among the more notable transactions in the sector this year.
Until parties confirm terms or an agreement is reached, the outcome remains uncertain.